Apimeds Pharmaceuticals US, Inc. (APUS)
4.60
-0.02
(-0.43%)
USD |
NYAM |
Oct 14, 10:11
Apimeds Pharmaceuticals US Market Cap : 6.942M for Oct. 14, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 13, 2026 | 6.972M |
| October 12, 2026 | 7.847M |
| October 09, 2026 | 7.576M |
| October 08, 2026 | 8.315M |
| October 07, 2026 | 10.64M |
| October 06, 2026 | 10.76M |
| October 05, 2026 | 6.927M |
| October 02, 2026 | 4.859M |
| October 01, 2026 | 6.187M |
| September 30, 2026 | 7.546M |
| September 29, 2026 | 7.576M |
| September 28, 2026 | 9.643M |
| September 25, 2026 | 10.94M |
| September 24, 2026 | 7.425M |
| September 23, 2026 | 3.456M |
| September 22, 2026 | 2.792M |
| September 21, 2026 | 2.520M |
| September 18, 2026 | 2.671M |
| September 17, 2026 | 2.520M |
| September 16, 2026 | 2.415M |
| September 15, 2026 | 2.475M |
| September 14, 2026 | 3.154M |
| September 11, 2026 | 3.177M |
| September 10, 2026 | 3.275M |
| September 09, 2026 | 3.456M |
| Date | Value |
|---|---|
| September 08, 2026 | 3.471M |
| September 04, 2026 | 3.652M |
| September 03, 2026 | 3.788M |
| September 02, 2026 | 3.969M |
| September 01, 2026 | 5.342M |
| August 31, 2026 | 5.855M |
| August 28, 2026 | 5.840M |
| August 27, 2026 | 5.961M |
| August 26, 2026 | 6.942M |
| August 25, 2026 | 7.500M |
| August 24, 2026 | 7.168M |
| August 21, 2026 | 7.304M |
| August 20, 2026 | 6.625M |
| August 19, 2026 | 6.625M |
| August 18, 2026 | 6.036M |
| August 17, 2026 | 6.459M |
| August 14, 2026 | 6.866M |
| August 13, 2026 | 7.093M |
| August 12, 2026 | 7.032M |
| August 11, 2026 | 5.823M |
| August 10, 2026 | 5.332M |
| August 07, 2026 | 5.320M |
| August 06, 2026 | 6.074M |
| August 05, 2026 | 5.848M |
| August 04, 2026 | 6.187M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.267B |
| Alnylam Pharmaceuticals, Inc. | 30.21B |
| Anika Therapeutics, Inc. | 272.48M |
| Savara, Inc. | 979.76M |
| Vericel Corp. | 2.047B |
Market Cap Related Metrics
| PEG Ratio | -0.0001 |
| Price to Book Value | 0.0652 |
| Price | 4.60 |
| Earnings Yield | -798.0% |
| PEGY Ratio | -0.0001 |